chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient received BNT162b2 (BNT162B2), on 27Mar2021 as dose 1, single (Lot number: ER8732, Expiration Date: 31Jul2021) at the age of 51 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Endometrial cyst removed" (not ongoing), notes: Endometrial cyst removed appx 6 years ago; "Endometriosis" (ongoing), notes: Endometrial cyst removed appx 6 years ago. There were no concomitant medications. The following information was reported: PSORIASIS (non-serious) with onset 2021, outcome "not recovered", described as "After dose 1: rash on bottom of left foot that eventually migrated to both feet and after dose 2: diagnosed as psoriasis". Therapeutic measures were taken as a result of psoriasis.  Additional Information: It was reported that after dose 1, the patient developed a rash on bottom of left foot that eventually migrated to both feet though not sure at what point and the patient initially thought it was just Athletes foot and treated it as such. After dose 2 , it was finally diagnosed as psoriasis.
4 hours after vaccine given in left arm, patient reported increased pain in left should.  Over the next three days the pain and difficulty in moving her arm at the shoulder intensified.  She was seen by an orthopedic physician on site three days after vaccine administration and was diagnosed with Tendonitis versus Rotator Cuff Injury.  She was prescribed steroids.  She reported feeling much better but not 100% at the time of this report.
Pt. Sleeping from 2100-1100. Woke up to get water and went back to sleep. Asleep from 1115-1300. Woke up and got a drink. Sitting at dinning room table. Reports feeling light headed, sweaty. Then pt fainted and fell off of chair to floor. Does not remember passing out. Possible vasovagal syncope. Pt went back to bed. Got out of bed again at 1700. No other symptoms.
Pt received H1N1 vaccination and within 1 min of standing up she lost consciousness, passed out, hit head, and regained consciousness.
the lymph nodes are swollen under her throat/for sick feeling in her lymph nodes (swollen; chills; dizziness; nausea/sick to the stomach; having hoarseness; problems speaking; in pain; her arm feels hard as a brick where he gave the injection; Her arm is hard like one of those body builders where their muscle sticks out; has been sick to the stomach; hot; Her arm has been hurting for over 11 days; This is a spontaneous report from a contactable consumer. A 74-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EK9231, Expiration date was not reported),via an unspecified route of administration, administered in Arm Left on 26Jan2021(age at vaccination 74 years) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 26Jan2021 the patient experienced her arm has been hurting for over 11 days , nausea/sick to the stomach, having hoarseness, problems speaking, in pain, her arm feels hard as a brick where he gave the injection, her arm is hard like one of those body builders where their muscle sticks out, has been sick to the stomach, feeling hot. chills on 30Jan2021, dizziness on 27Jan2021 ,sick feeling in her lymph nodes (swollen) /lymph nodes are swollen under her throat feeling on 08Feb2021. Patient stated She just started having chills again and they come and go, and she never knows. She stated everyone else said they had pain 2-3 days so it must be the way he gave it to her. She asked are these normal side effects. Is it normal for them to last this long?Is there such a thing as having a bad batch. Her second dose is scheduled 20Feb2021, four days late. the man who gave her shot told her to put out her arm shoulder length and stated, 'make a muscle by squeezing your hand' and he didn't use an alcohol swap and then he put a Band-Aid on it. The outcome of events was dizziness was recovered on 31Jan2021, her arm is hard like one of those body builders where their muscle sticks out was unknown, rest of all events was not recovered.  Is there a Product Complaint: Yes Description of Product Complaint: Description of complaint: Covid vaccine: Stated that it must have been a bad batch.  Product strength and count size dispensed: unknown strength; one count Is a sample of the product available to be returned, if requested (Y/N): N Packaging sealed and intact? Unknown  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
This is an initial spontaneous report by a contactable physician. A female patient received PREVNAR 13 (Lot number: G54897, Expiration Date: 09Jan2014) unknown dose unknown, frequency ,unknown anatomical location of the administration for an unknown indication in May2013. Relevant medical history was unknown. Relevant concomitant medications were unknown. Vaccines given on the same day was unknown. Vaccines taken within the last four weeks were unknown. In 2013 she experienced pneumococcal pneumonia, pneumococcal sepsis and an unspecified condition to which she passed away. Relevant lab data was unknown. It was unknown if an autopsy was performed. At the time of report she had not recovered from an unspecified condition. At the time of report the clinical outcome for the other events were unknown.
BODY ACHES; VOMITING; CHILLS; FEVER; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19, and concurrent conditions included heart disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 08:45 for prophylactic vaccination. The batch number was not reported and it has been requested. No concomitant medications were reported. On DEC-2020, Laboratory data included: Convalescent plasma transfusion (NR: not provided) still have antibodies present. On 10-MAR-2021 16:30, the subject experienced body aches. On 10-MAR-2021 16:30, the subject experienced vomiting. On 10-MAR-2021 16:30, the subject experienced chills. On 10-MAR-2021 16:30, the subject experienced fever. On 10-MAR-2021 16:30, the subject experienced nausea. On 10-MAR-2021 16:30, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 12-MAR-2021, and was recovering from body aches, chills, nausea, vomiting, and headache. This report was non-serious.
Patient developed a fever the evening of 6/25 following the vaccine administration earlier that day. He continued with a fever on 6/26. We were awakened in the middle on the night (6/26 into 6/27) to patient convulsing. We called 911 and he was taken to the hospital where they confirmed that he had suffered a seizure.
Information has been received from a nurse practitioner concerning a 24 year old female, with no drug reactions or allergies and no pertinent medical history, who on 27-MAR-1984 was vaccinated with a first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). In DEC 1991 the patient was vaccinated with a second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Subsequent to receiving two doses of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) as a child, the patient now has a negative mumps titer. No reaction was reported with this event. There was no concomitant therapy. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Following administration of Influenza vax, pt devel erythema & edema @ inject site; Reporter though vax was injected into the triceps instead of deltoid area;
Sensation of needle pricks that lasted less than a second all over her body with some erythema.  She came in on 5/8/15 and said it was getting worse.  I told her to call Dr. and have him look at it so he could prescribe medication.
Patient received second dose 4/21/21 however, she wanted us to note that she developed a localized rash after her first dose (at injection site).  Rash eventually resolved on its own without medical intervention
Had shot on 11/29/16 around 11:30 AM. at 6:30 had to go to ER: experienced breathing problem. Complete red and sore eyes with white fluid coming out when rubbed, sore throat with swallowing problem. Was given 4 medications and injection at hospital observed for one hour. Sent home with prescription for CLARITIN and ZANTAC for 3 days.
mild tingling sensation on the back part of my tongue; metal taste; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via an unspecified route of administration, in the left arm on 29Jan2021 at 09:30 (at the age of 58-years-old) as a single dose for covid-19 immunisation. Patient's medical history included cardiovascular disease, 2 stents and hypertension (on medications). The patient was not aware of any allergies to medications, food or other products. Patient did not receive any other vaccines within 4 weeks prior to vaccination. Concomitant medications included (acetylsalicylic acid) LD ASPIRIN, metoprolol succinate (TOPROL), clopidogrel bisulfate (PLAVIX), valsartan (DIOVAN), atorvastatin (LIPITOR) and ergocalciferol (VIT D). Prior to the vaccination the patient was not diagnosed with COVID-19. On 29Jan2021 at 09:30, the patient experienced mild tingling sensation on the back part of my tongue and metal taste. Sensation peaked at approx. 30-40 minutes then started to subside. Fully subsided after approx. 2 hours. Treatment was received. Patient underwent Blood pressure measurement, pulse rate and oxygen saturation on 29Jan2021 and results were unknown. Since the vaccination the patient had not been tested for COVID-19. The outcome of the event paraesthesia was recovered on 29Jan2021 at 11:30 and Dysgeusia was recovered on an unspecified date in 2021.
Paraesthesia; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Paraesthesia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Paraesthesia). At the time of the report, PARAESTHESIA (Paraesthesia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products are reported.  No treatment information was reported.   Reporter did not allow further contact
Not feeling good; Sore throat; running  nose; Sore arms; Hurting joint; Getting tired; A spontaneous report was received from a consumer who was also a 56-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273)and experienced not feeling good (malaise), sore throat (oropharyngeal pain), running nose (rhinorrhea), tired (fatigue), hurting joint (arthralgia), and sore arms (pain in extremity).  The patient's medical history was not provided. The patient was taking no concomitant medications.  On 29 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.     On 30 Dec 2020, the day after receiving the vaccine, the patient experienced tiredness. She did not feel good, had a sore throat, running nose, joints that hurt, and sore arms. The patient stated she felt worse.   Treatment for the event included cold medicine on the 30 Dec 2020.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The outcome for the events, not feeling good, sore throat, running nose, tired, hurting joint, and sore arms, was unknown.; Reporter's Comments: This case concerns a 56-year-old female who experienced NS events of unexpected malaise, oropharyngeal pain, rhinorrhea, pain in extremity and expected arthralgia and fatigue.  Event onset occurred Day 2 after the first dose of mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Follow up or original: Surgery on the 17th.  They are calling a cavernous malformation that erupted or hemorrhaged. That was from four different second opinions. Something got in there to plug it up. Eyelids will not open. Her eye is crossed aiming off to the side or she has double vision. SHe has no taste. Very little hearing on left side ear. She is numb inside her mouth - she keeps biting her lip. Her right leg drags - the same that the day we left the hospital on 7/19/2021. They sent her home with pain reliever but she didn't need much - she's not in pain. They put her on steroids two separate times. They sent her home with sodium tablets as well. She's having cognitive issues. Not remembering very well. Today she is in the hospital because we were at a doctor yesterday and she came home and lost her voice last night and this morning it got worse and then her eyes were getting worse. Then her voice got better later. Went and got COVID test  at about 11:00. Then after that she complained about worsening symptoms and called  advice nurse - and they said to take her to ER .  Eyes were bothering her - she claims since the surgery she only has about 10% vision THey found a cut on her leg that was infected and causing low white blood cell count. They are keeping her overnight. Her second operation is set up for November 8th - this one will remove the eruption because it has moved. Last time it was in a place where they were unable to remove it. They did a CAT scan on her today - they said everything looked the same as far as the brain issue. No results yet from the COVID test.
This spontaneous report as received from a doctor of pharmacy refers to a patient of unknown age with no known allergies. The patient was vaccinated with a dose of ZOSTAVAX (lot # H01230 exp date 30-NOV-2013; lot for diluent G018478 exp. date November 2013) (dose and route not reported) on 16-NOV-2012. No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on an unspecified date (in November 2012) ZOSTAVAX created a "mosquito bite" appearance on the patient's upper arm. The pharmacist reported that she was unable to push the full dose of vaccine into the patients' arms. She followed up with the patient a few days later and the patient stated that the wheal "went away". No treatment information was reported. It was unknown if the patient sought medical attention. The relatedness for mosquito bite appearance on the patient's upper arm is unknown for ZOSTAVAX. This is one of several reports received from the same source. Additional information has been requested.
Febrile seizure. Temp. 101.2 lasting 2 minutes. No convulsing just lifeless. Went to hospital.
Case number PHEH2013US023973 is an initial spontaneous report received from a consumer on 12 Nov 2013. This report refers to a 66-year-old male patient. His medical history included eye migraines 2 to 3 times a year and concomitant medications were not reported. He was vaccinated with an intramuscular dose of FLUVIRIN (batch number: not reported) on 06 Nov 2013. It was reported that 15 minutes after vaccination, he experienced migraine headache and since then he had it daily. He reported that his doctor told him that he experienced eye migraine of unknown cause. The event outcome was reported as condition unchanged.
PATIENT RECEIVED HD FLU SHOT INSTEAD OF REGULAR WHILE IN LINE WITH RESIDENTS FOR FLU CLINIC. FACILITY TOLD THE NAMES OF PATIENTS WHO RECEIVED THE HD FLU SHOT FOR THOSE 65 AND OLDER WHO WERE LESS THAN 65. FACILITY TO TELL PATIENTS AND MONITOR. NO REPORTED ADVERSE EFFECTS FROM FACILITY
Patient received Pediatric Pfizer covid vaccine at 11:15.  Returned with mom 25 minutes after walking to other side of store reporting that patient vomited twice.  Patient reported it felt funny to breath with mask and took off and then vomited.  Stomach and breathing felt better after vomiting twice. She felt nervous and doesnt like needles. Denies itching, swelling, difficulty breathing. No rash or hives. Consulted with nurse practitioner at store.  BP taken was normal. Mom gave oral benadryl. Observed additional 15 -30min. Patient reported no symptoms at noon. Mom calling physician.
Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O11M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DIZZINESS (Dizzy). At the time of the report, DIZZINESS (Dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient felt dizzy after 36 hours of the vaccine. Patient stated that he is using other medication.  No Treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded. NNI
Fatigue; dizziness; memory fog; SOB; This is a spontaneous report from a contactable Other Health Professional (patient herself). A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EL1284) via an unspecified route of administration in left arm on 12Jan2021 as dose 2, single (at the age of 50-years-old) for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient medical history included diabetes mellitus (DM), hypertension (HTN), cholesterol (blood cholesterol) and sleep apnea. Patient known allergies was reported as NKA. The concomitant medications in two weeks included metformin hydrochloride (METFORMIN ER, dulaglutide (TRULICITY), insulin glargine (BASAGLAR), lisinopril (LISINOPRIL) and atorvastatin calcium (ATO). Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EH9899) via an unspecified route of administration in left arm on 22Dec2020 as dose 1, single for COVID-19 immunization. Vaccination facility type was reported as Hospital. The patient did not have any other vaccine in four weeks and did not test for covid prior to vaccination. The patient experienced fatigue, dizziness, memory fog and short of breath (SOB) on 12Jan2021. The events resulted in a visit to emergency room/department or urgent care. The patient underwent lab tests and procedures which included patient being tested for COVID-19, post vaccination as COVID-19 virus test (Sars-Cov-2 test (nasal swab)) which was negative on 15Jan2021. The patient did not receive any treatment for the adverse events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Swelling and pain at the injection site 12 hours after vaccination. The pain progressed distally to the elbow and resolved after 3 day. On 21Feb 2021, Tenderness,warmth, swelling and  erythema was noted 4 inches below the injection site. A mild non-itchy rash with induration approximately 4 inches was noted. The tenderness, warmth at the site and induration has not resolved at the time of report. No medication was taken for the symptoms. No  medical intervention needed.
Patient was given 2 doses of Hep B in December of 2014 and 1 was an extra shot too close in proximity of the previous shot (one was given 12/4/14 and the other 12/22/14). There are currently no known adversities but I would like to have a record of this in case there are any long term side effects.
Diarrhea, followed by worsening pruritic rash over face and perioral hypopigmentation.
Ash or medicine smell/taste in nasal passages; Ash or medicine smell/taste in nasal passages; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin, dogs, feathers, mold and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced ash or medicine smell/taste in nasal passages. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ash or medicine smell/taste in nasal passages was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
about 5 minutes after getting the vaccine the patient started having vasovagal syncope and started to pass out. I came to know through my technician and I had to jump to the patient and make him lie down in supine position with EMS activation steps alerted to the technician. Patient was responding and had a pulse of 70 / minute and did not completely pass out. Laying him down in supine position helped with enhancing the circulation and he quickly started feeling better within 20 to 30 seconds. and therefore EMS was called off and I kept observing the patient to ensure that he was responding and starting to feel better. We kept the patient with us for about 30 minutes and he was feeling fine. I called him back at 3:45 pm to see how he was doing and he was doing fine .
I initially got sick from being vaccinated but recovered in a couple of days.  Subsequently  around 2/18/21 I began to slur words.  Doctors became worried I had had a stroke but believe now that I did not initally the thought was I had ALS.  At this point in time the doctors are still ruling out  things but believe my slurring was caused by a reaction to the vaccine in combination with two weakened nerves caused by radiation to the hypoglossal nerve and another nerve which has caused my tongue to permanently atrophy.
Patient noticed a red circular reaction on left arm where vaccines were administered. Asked the patient if it was warm or hard to the touch, patient declined any of these reactions.
This spontaneous report was received from a patient's mother who referred to her daughter the female patient of an unknown age. the patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. In July 2018, the patient was vaccinated with the second dose of M-M-R II injection (exact dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On unknown dates in 2018, the patient had unspecified tests performed that showed titers were still negative. No other symptoms or specifics were provided. There was no treatment given for the event. At the time of this report, the outcome of the event was reported as not recovered. The causality assessment between the event and  M-M-R II was not provided.